180 Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

180 Wealth Advisors, LLC

  • $629 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
BUY
$902.69 - $993.35 $204,910 - $225,490
227 New
227 $218,000
Q1 2022

Apr 22, 2022
SELL
$595.12 - $698.43 $199,960 - $234,672
-336 Closed
0 $0
Q4 2021

Jan 26, 2022
BUY
$543.48 - $670.97 $182,609 - $225,445
336 New
336 $209,000
Q1 2018

Jun 01, 2018
SELL
$315.82 - $393.78 $177,490 - $221,304
-562 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$358.63 - $469.95 $201,550 - $264,111
562
562 $211,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track 180 Wealth Advisors, LLC Portfolio

Follow 180 Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 180 Wealth Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email